Since the first description, the phenotype associated to ADCY5 mutations has largely broadened and consequently, the original term FDFM has been replaced by a more comprehensive definition (ADCY5-related dyskinesias). The gene discussed is ADCY5; the disease is drug-induced dyskinesia.